Integrated mRNA Support Facilitates mRNA Product Development and Commercialization
November 19, 2021
Tags:
David Stevens and Michael Wourms of Arranta Bio discuss how the company is addressing the highly fragmented manufacturing space for mRNA vaccines and therapeutics issue by offering an integrated solution from mRNA raw material production to aseptic filling and for clinical trial material to commercial products.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
.svg)
